The biopharmaceutical industry is thriving, fueled by groundbreaking advancements in treating cancers, Alzheimer’s, obesity, diabetes, and autoimmune diseases. At the core of this explosive growth lies a fusion of cutting-edge research and artificial intelligence (AI)-driven innovations, speeding up drug development and enhancing treatment outcomes while slashing costs.
While big pharma giants like Eli Lilly and Company (LLY), Pfizer (PFE), and Merck (MRK) grab the headlines, it's the clinical-stage biopharma companies that are often the hidden gems.
